Sui-Yuan Chang to Female
This is a "connection" page, showing publications Sui-Yuan Chang has written about Female.
Connection Strength
0.016
-
The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient. J Infect. 2020 07; 81(1):147-178.
Score: 0.003
-
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
Score: 0.003
-
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy. Sci Rep. 2017 11 23; 7(1):16187.
Score: 0.002
-
Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey. BMJ Open. 2017 Oct 16; 7(10):e015142.
Score: 0.002
-
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016; 11(12):e0169228.
Score: 0.002
-
Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor. J Infect Chemother. 2014 Aug; 20(8):465-70.
Score: 0.002
-
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2007 Nov 01; 45(9):1221-9.
Score: 0.001